We are there for our patients – even in crisis regions.
We are there for our patients – even in crisis regions.
Search
Our innovation strategy
Our Innovation Strategy at Boehringer Ingelheim in Research and Development
Oncology Translational Science
Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Data Science: Revolutionizing research and development with data driven insights
Using data in pharmaceutical research to better address patient needs
Biotherapeutics Discovery
Our committed team of scientists are using all their experience and knowledge to forge new research paths, engineer new molecules and do whatever it takes to make sure that no patient is left behind in our search for the next breakthrough.
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
What is my role as a patient or a caregiver forpatient safety & pharmacovigilance
What is being done for patient safety by different stakeholders
What ispharmacovigilance& its role on patient safety
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Innovation in Oncology and Cancer Immunology Research
We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Reimagining digital healthcare worldwide
How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
Artrial Fibrillation
Artrial Fibrillation
Human Health Partnering
Human Health Partnering
Cancer
Cancer
Our Responsibility
Human Health Our Responsibility
Clinical Studies
Clinical Studies
Fostering Science
Fostering Science
Science & Innovation
Innovation Wir verbessern die Gesundheit und die Lebensqualität von Patienten. Das ist seit 130 Jahren das zentrale Ziel des forschenden Pharmaunternehmens Boehringer Ingelheim.
Skin Diseases
Skin Diseases
Grass Roots
Grass Roots
What Our Partners Say
What Our Partners Say